Second-Line Treatment for Knee Osteoarthritis and Tendinopathies After First-Line Failure
For knee osteoarthritis in Medicare patients who have failed first-line measures, proceed directly to total knee arthroplasty evaluation rather than pursuing additional nonoperative treatments, as the evidence shows these interventions provide limited efficacy and primarily delay definitive care. 1
Knee Osteoarthritis: Second-Line Approach
The Evidence Against Delaying Surgery
The 2023 ACR/AAHKS guideline explicitly recommends against delaying total joint arthroplasty (TJA) for additional nonoperative treatments including physical therapy, NSAIDs, braces, ambulatory aids, or intraarticular injections in patients with moderate-to-severe symptomatic OA who have already tried conservative management 1. This represents the highest-quality, most recent guidance available.
Key findings supporting immediate surgical evaluation:
- Only 9% of patients deemed appropriate for TKA received timely surgery (within 2 years)
- 91% experienced delays that led to increased pain, functional limitations, and disability
- 93% of patients surveyed stated they would not want mandatory additional conservative treatment before surgery 1
Medicare-Reimbursed Options If Surgery Is Not Yet Indicated
If the patient does not yet meet criteria for moderate-to-severe symptomatic OA requiring arthroplasty, Medicare covers:
Pharmacologic:
- NSAIDs (oral or topical) - provide short-term pain relief but no long-term outcome benefit 2, 3
- Intraarticular corticosteroid injections (knee only) - consistently recommended across high-quality guidelines 3
- Paracetamol/acetaminophen - though evidence is mixed and recommendations less consistent 3, 4
Avoid:
- Hyaluronic acid injections for hip OA - consistently recommended against 3
- Hyaluronic acid for knee OA - inconsistent recommendations, comprises only 5.6% of total OA costs, and primarily delays surgery by median 10.7 months without clear benefit 5, 3
- Stem cell injections - consistently recommended against 3
- Arthroscopy - consistently recommended against 3
Critical Pitfall
Coverage determination policies from insurance companies often mandate additional nonoperative treatments before approving surgery, but these policies are not evidence-based - less than 10% of cited literature actually studied patients with moderate-to-severe OA indicated for TJA 1. Do not allow administrative barriers to delay appropriate surgical referral.
Tendinopathies: Second-Line Approach
Structured Treatment Algorithm
For tendinopathies failing first-line measures (relative rest, ice, activity modification):
1. Eccentric Strengthening Exercises
- Most effective treatment that may reverse degenerative changes
- Evidence level B 2
2. NSAIDs for Short-Term Pain Relief
- Oral or topical formulations
- Topical may have fewer systemic effects
- Provide acute relief but no long-term outcome benefit 2
3. Local Corticosteroid Injections
- More effective than oral NSAIDs for acute-phase pain
- Do not alter long-term outcomes
- Evidence level B 2
4. Consider Extracorporeal Shock Wave Therapy
- Safe, noninvasive, effective for chronic tendinopathies
- Expensive but evidence-supported
- Evidence level B 2
5. Surgical Referral
- Reserve for patients failing 3-6 months of conservative therapy
- Effective in carefully selected patients
- Evidence level B 2
What NOT to Pursue
- Therapeutic ultrasonography - uncertain benefit 2
- Corticosteroid iontophoresis - uncertain benefit 2
- Phonophoresis - uncertain benefit 2
- Orthotics/braces - no conclusive recommendations; use clinical judgment 2
Important Context
Medicare coverage for tendinopathy treatments is inconsistent. For example, arthrocentesis is covered 100% for knee OA but 0% for TMJ OA, highlighting coverage disparities 6. Verify specific coverage before ordering treatments.
Timeline Expectations
Patients typically present after prolonged symptoms when acute inflammation has subsided and degenerative changes dominate 2. Pain progresses from activity-related to rest pain. Muscle atrophy on examination indicates chronicity and suggests more aggressive intervention may be needed.